{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:21:30Z","timestamp":1790461290065,"version":"4.1.0"},"reference-count":143,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>IgA, previously called Henoch-Sch\u00f6nlein vasculitis, is an essential immune component that drives the host immune response to the external environment. As IgA has the unique characteristic of a flexible response to broad types of microorganisms, it sometimes causes an autoreactive response in the host human body. IgA vasculitis and related organ dysfunction are representative IgA-mediated autoimmune diseases; bacterial and viral infections often trigger IgA vasculitis. Recent drug developments and the presence of COVID-19 have revealed that these agents can also trigger IgA vasculitis. These findings provide a novel understanding of the pathogenesis of IgA vasculitis. In this review, we focus on the characteristics of IgA and symptoms of IgA vasculitis and other organ dysfunction. We also mention the therapeutic approach, biomarkers, novel triggers for IgA vasculitis, and epigenetic modifications in patients with IgA vasculitis.<\/jats:p>","DOI":"10.3390\/ijms22147538","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T10:13:42Z","timestamp":1626257622000},"page":"7538","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes"],"prefix":"10.3390","volume":"22","author":[{"given":"Hitomi","family":"Sugino","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health,1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu, Fukuoka 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health,1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu, Fukuoka 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health,1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu, Fukuoka 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","article-title":"Genetics of immunoglobulin-A vasculitis (Henoch-Sch\u00f6nlein purpura): An updated review","volume":"17","author":"Genre","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-018-0735-3","article-title":"IgA Vasculitis: Genetics and Clinical and Therapeutic Management","volume":"20","author":"Pina","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/art.38979","article-title":"HLA-DRB1 association with Henoch-Schonlein purpura","volume":"67","author":"Genre","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-015-0622-5","article-title":"Association of HLA-B*41:02 with Henoch-Sch\u00f6nlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status","volume":"17","author":"Genre","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41598-017-03915-2","article-title":"A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis","volume":"7","author":"Carmona","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_6","first-page":"1404","article-title":"Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Sch\u00f6nlein purpura","volume":"29","author":"Amoli","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_7","first-page":"2367","article-title":"Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis","volume":"29","author":"Amoli","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Carmona, E.G., Garc\u00eda-Gim\u00e9nez, J.A., L\u00f3pez-Mej\u00edas, R., Khor, C.C., Lee, J.K., Taskiran, E., Ozen, S., Hocevar, A., Liu, L., and Gorenjak, M. (2021). Identification of a shared genetic risk locus for Kawasaki disease and IgA vasculitis by a cross-phenotype meta-analysis. Rheumatology.","DOI":"10.1093\/rheumatology\/keab443"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4161\/mabs.3.4.16092","article-title":"Immunoglobulin A: A next generation of therapeutic antibodies?","volume":"3","author":"Bakema","year":"2011","journal-title":"MAbs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1471-4906(01)01873-7","article-title":"IgA and the IgA Fc receptor","volume":"22","author":"Damen","year":"2001","journal-title":"Trends Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/jvi.55.2.475-482.1985","article-title":"Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies","volume":"55","author":"Fuller","year":"1985","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fimmu.2012.00100","article-title":"Functional flexibility of intestinal IgA\u2014Broadening the fine line","volume":"3","author":"Slack","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3322","article-title":"New concepts in the generation and functions of IgA","volume":"12","author":"Pabst","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Saito, S., Sano, K., Suzuki, T., Ainai, A., Taga, Y., Ueno, T., Tabata, K., Saito, K., Wada, Y., and Ohara, Y. (2019). IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007427"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1107\/S0907444912048664","article-title":"Structure of a human IgA1 Fab fragment at 1.55 \u00c5 resolution: Potential effect of the constant domains on antigen-affinity modulation","volume":"69","author":"Correa","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.str.2004.12.012","article-title":"Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces","volume":"13","author":"Li","year":"2005","journal-title":"Structure"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0021-9258(20)71190-7","article-title":"Antigen-antibody interaction. The immunodominant region of EDP208 pili","volume":"260","author":"Worobec","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1523-1755.2002.00477.x","article-title":"Interactions of human mesangial cells with IgA and IgA-containing immune complexes","volume":"62","author":"Novak","year":"2002","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2567.1999.00755.x","article-title":"Natural polyreactive immunoglobulin A antibodies produced in mouse Peyer\u2019s patches","volume":"97","author":"Shimoda","year":"1999","journal-title":"Immunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1128\/iai.65.10.3997-4004.1997","article-title":"Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans","volume":"65","author":"Quan","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"649112","DOI":"10.3389\/fimmu.2021.649112","article-title":"Innate Mechanisms in Selective IgA Deficiency","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1442-200X.1993.tb03020.x","article-title":"Serum anti-streptococcal IgA, IgG and IgM antibodies in IgA-associated diseases","volume":"35","author":"Nakatsuka","year":"1993","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1536\/ihj.19-446","article-title":"IgA Vasculitis Triggered by Infective Endocarditis of Pulmonary Artery with Congenitally Corrected Transposition of the Great Arteries","volume":"61","author":"Akagi","year":"2020","journal-title":"Int. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000167450","article-title":"Henoch-Sch\u00f6nlein purpura complicating staphylococcal endocarditis in a heroin addict","volume":"7","author":"Montoliu","year":"1987","journal-title":"Am. J. Nephrol."},{"key":"ref_25","first-page":"1296","article-title":"Stroke in Henoch-Sch\u00f6nlein purpura associated with methicillin-resistant Staphylococcus aureus septicemia: Report of a case and review of the literature","volume":"91","author":"Temkiatvises","year":"2008","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10157-007-0024-3","article-title":"Henoch-Sch\u00f6nlein purpura due to methicillin-sensitive Staphylococcus aureus bacteremia from central venous catheterization","volume":"12","author":"Uggeri","year":"2008","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_27","first-page":"687","article-title":"Henoch-Sch\u00f6nlein purpura after postoperative Staphylococcus aureus infection with hepatic IgA nephropathy","volume":"19","author":"Kitamura","year":"2006","journal-title":"J. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2796.2001.00815.x","article-title":"Specific T-cell receptor usage with cytokinemia in Henoch-Sch\u00f6nlein purpura nephritis associated with Staphylococcus aureus infection","volume":"249","author":"Hirayama","year":"2001","journal-title":"J. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1525-1470.2009.01039.x","article-title":"Henoch-Sch\u00f6nlein purpura associated with helicobacter pylori infection: The pathogenic roles of IgA, C3, and cryoglobulins?","volume":"26","author":"Shin","year":"2009","journal-title":"Pediatr. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08916930232000114535","article-title":"Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Sch\u00f6nlein purpura","volume":"36","author":"Szekanecz","year":"2003","journal-title":"Autoimmunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-2007-973561","article-title":"Early and late onset manifestations of cerebral vasculitis related to varicella zoster","volume":"29","author":"Ramaekers","year":"1998","journal-title":"Neuropediatrics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.14948","article-title":"IgA vasculitis with severe gastrointestinal symptoms may be an unusual manifestation of varicella zoster virus reactivation","volume":"176","author":"Ushigome","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_33","first-page":"681","article-title":"Hepatitis B virus infection and Sch\u00f6nlein-Henoch purpura","volume":"138","author":"Maggiore","year":"1984","journal-title":"Am. J. Dis. Child."},{"key":"ref_34","first-page":"232","article-title":"Henoch-Sch\u00f6nlein syndrome associated with human Parvovirus B19 primary infection","volume":"9","author":"Veraldi","year":"1999","journal-title":"Eur. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1034\/j.1600-0560.2002.291006.x","article-title":"Parvovirus B19 associated adult Henoch Sch\u00f6nlein purpura","volume":"29","author":"Cioc","year":"2002","journal-title":"J. Cutan. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.reuma.2018.03.010","article-title":"IgA vasculitis as a presentation of human immunodeficiency virus infection","volume":"16","author":"Suarez","year":"2020","journal-title":"Reumatol. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Matsumura, M., Komeda, Y., Watanabe, T., and Kudo, M. (2020). Purpura-free small intestinal IgA vasculitis complicated by cytomegalovirus reactivation. BMJ Case Rep., 13.","DOI":"10.1136\/bcr-2020-235042"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00296-020-04586-5","article-title":"Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: A triggering factor or a rare complication of the disease? A case-based review","volume":"40","author":"Kounatidis","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000102455","article-title":"IgA nephropathy and Henoch-Schoenlein purpura nephritis: Aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells","volume":"157","author":"Novak","year":"2007","journal-title":"Contrib. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.immuni.2019.05.021","article-title":"Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation","volume":"51","author":"Wakita","year":"2019","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0738-081X(91)90030-O","article-title":"Linear IgA bullous dermatosis of adults","volume":"9","author":"Chorzelski","year":"1991","journal-title":"Clin. Dermatol."},{"key":"ref_44","first-page":"351","article-title":"IgA and Fc\u03b1RI: Versatile Players in Homeostasis, Infection, and Autoimmunity","volume":"9","year":"2020","journal-title":"Immunotargets Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin A Fc receptor Fc\u03b1RI; Its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imcb.12306","article-title":"Serum IgA Fc effector functions in infectious disease and cancer","volume":"98","author":"Davis","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and Fc\u03b1RI: Pathological Roles and Therapeutic Opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/76261","article-title":"FcalphaRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity","volume":"6","author":"Damen","year":"2000","journal-title":"Nat. Med."},{"key":"ref_49","first-page":"e1","article-title":"Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4","volume":"137","author":"Tuk","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.172.6.1535","article-title":"Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration","volume":"172","author":"Clauss","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_51","first-page":"2269","article-title":"Vascular endothelial growth factor in Henoch-Schonlein purpura","volume":"28","author":"Topaloglu","year":"2001","journal-title":"J. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Yang, Y.H., Tsai, I.J., Chang, C.J., Chuang, Y.H., Hsu, H.Y., and Chiang, B.L. (2015). The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Sch\u00f6nlein Purpura. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120411"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/cs0810477","article-title":"Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis","volume":"81","author":"Lhotta","year":"1991","journal-title":"Clin. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Pillebout, E., Jamin, A., Ayari, H., Housset, P., Pierre, M., Sauvaget, V., Viglietti, D., Deschenes, G., Monteiro, R.C., and Berthelot, L. (2017). Biomarkers of IgA vasculitis nephritis in children. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188718"},{"key":"ref_55","first-page":"1579","article-title":"Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort","volume":"33","author":"Berthelot","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10067-018-4234-8","article-title":"Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis","volume":"38","author":"Kuret","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1998.00745.x","article-title":"Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Sch\u00f6nlein purpura nephritis, and a potential target of immunoglobulin therapy?","volume":"114","author":"Rostoker","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.intimp.2016.07.032","article-title":"Circulating midkine in children with Henoch-Sch\u00f6nlein purpura: Clinical implications","volume":"39","author":"Su","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clinbiochem.2017.11.006","article-title":"Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura","volume":"52","author":"Purevdorj","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/ced.12089","article-title":"Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Sch\u00f6nlein purpura","volume":"38","author":"Kimura","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"De Sousa-Pereira, P., and Woof, J.M. (2019). IgA: Structure, Function, and Developability. Antibodies, 8.","DOI":"10.3390\/antib8040057"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hastings, M.C., Rizk, D.V., Kiryluk, K., Nelson, R., Zahr, R.S., Novak, J., and Wyatt, R.J. (2021). IgA vasculitis with nephritis: Update of pathogenesis with clinical implications. Pediatr. Nephrol.","DOI":"10.1007\/s00467-021-04950-y"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5301\/ijao.5000223","article-title":"Effects of hemoperfusion in the treatment of childhood Henoch-Sch\u00f6nlein purpura nephritis","volume":"36","author":"Chen","year":"2013","journal-title":"Int. J. Artif. Organs"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-020-05166-5","article-title":"Multisystemic manifestations of IgA vasculitis","volume":"40","author":"Du","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.1996.d01-813.x","article-title":"Induction of IL-4 by platelet-activating factor","volume":"106","author":"Huang","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-3476(68)80324-5","article-title":"The development of immunoglobulin levels in man","volume":"72","author":"Allansmith","year":"1968","journal-title":"J. Pediatr."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Van Twillert, I., van Gaans-van den Brink, J.A., Poelen, M.C., Helm, K., Kuipers, B., Schipper, M., Boog, C.J., Verheij, T.J., Versteegh, F.G., and van Els, C.A. (2014). Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085227"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/166.3.486","article-title":"Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection","volume":"166","author":"Szelc","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1158\/1078-0432.CCR-05-1824","article-title":"Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: A major nosologic difference with adult tumors","volume":"12","author":"Vakkila","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ekir.2020.08.016","article-title":"IgA Vasculitis with Nephritis (Henoch-Sch\u00f6nlein Purpura) in a COVID-19 Patient","volume":"5","author":"Suso","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3928\/19382359-20201211-01","article-title":"A Child with COVID-19 and Immunoglobulin A Vasculitis","volume":"50","author":"Hoskins","year":"2021","journal-title":"Pediatr. Ann."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/art.41428","article-title":"COVID-19-Related IgA Vasculitis","volume":"72","author":"Allez","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e14551","DOI":"10.1111\/dth.14551","article-title":"Possible association between IgA vasculitis and COVID-19","volume":"34","author":"Sandhu","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e239910","DOI":"10.1136\/bcr-2020-239910","article-title":"A child with Henoch-Schonlein purpura secondary to a COVID-19 infection","volume":"14","author":"AlGhoozi","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/INF.0000000000003001","article-title":"Purpurona: A Novel Report of COVID-19-Related Henoch-Schonlein Purpura in a Child","volume":"40","author":"Jacobi","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Li, N.L., Papini, A.B., Shao, T., and Girard, L. (2021). Immunoglobulin-A Vasculitis with Renal Involvement in a Patient With COVID-19: A Case Report and Review of Acute Kidney Injury Related to SARS-CoV-2. Can. J. Kidney Health Dis., 8.","DOI":"10.1177\/2054358121991684"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(20)30553-5","article-title":"Health security capacities in the context of COVID-19 outbreak: An analysis of International Health Regulations annual report data from 182 countries","volume":"395","author":"Kandel","year":"2020","journal-title":"Lancet"},{"key":"ref_79","first-page":"710","article-title":"Vasculitides induced by TNFalpha antagonists: A study in 39 patients in France","volume":"73","year":"2006","journal-title":"Jt. Bone Spine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03009742.2020.1732460","article-title":"Immunoglobulin A vasculitis associated with inflammatory bowel disease: A retrospective cohort study","volume":"50","author":"Crowson","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s10067-020-05364-1","article-title":"IgA vasculitis during secukinumab therapy","volume":"40","author":"Perkovic","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/j.jaad.2011.06.013","article-title":"A high serum concentration of chemerin in pustular dermatitis paradoxically induced by etanercept","volume":"66","author":"Sawada","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000095033","article-title":"Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: Three further cases and current overview","volume":"213","author":"Pirard","year":"2006","journal-title":"Dermatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(07)60474-7","article-title":"Clinical update: Henoch-Sch\u00f6nlein purpura","volume":"369","author":"Saulsbury","year":"2007","journal-title":"Lancet"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0016-5107(02)70376-3","article-title":"GI involvement in Henoch-Sch\u00f6nlein purpura","volume":"56","author":"Esaki","year":"2002","journal-title":"Gastrointest. Endosc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Sch\u00f6nlein purpura in adulthood and childhood: Two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Sch\u00f6nlein purpura: A randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Huber, A.M., King, J., McLaine, P., Klassen, T., and Pothos, M. (2004). A randomized, placebo-controlled trial of prednisone in early Henoch Sch\u00f6nlein Purpura [ISRCTN85109383]. BMC Med., 2.","DOI":"10.1186\/1741-7015-2-7"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: A randomised controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: A rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/art.1780080438","article-title":"Colchicine inhibition of chemotaxis","volume":"8","author":"Caner","year":"1965","journal-title":"Arthritis Rheum."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.1780160608","article-title":"Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: Inhibition by colchicine and cortisol but not by salicylate","volume":"16","author":"Wright","year":"1973","journal-title":"Arthritis Rheum."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3345\/kjp.2019.00514","article-title":"Treatment of refractory IgA vasculitis with dapsone: A systematic review","volume":"63","author":"Lee","year":"2020","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D330M4B5KR","article-title":"Dapsone","volume":"8","author":"Wolf","year":"2002","journal-title":"Dermatol. Online J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mehy.2017.07.018","article-title":"Dapsone as a potential treatment option for Henoch-Sch\u00f6nlein Purpura (HSP)","volume":"108","author":"Lee","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_98","first-page":"220","article-title":"Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein)","volume":"71","author":"Bech","year":"2013","journal-title":"Neth. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/adc.2004.061598","article-title":"Dapsone therapy for Henoch-Sch\u00f6nlein purpura: A case series","volume":"90","author":"Iqbal","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/pgmj.67.793.961","article-title":"Dapsone in Henoch-Sch\u00f6nlein purpura\u2014Worth a trial","volume":"67","author":"Hoffbrand","year":"1991","journal-title":"Postgrad. Med. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00431-019-03409-5","article-title":"Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): Case series and a review of the literature","volume":"178","author":"Roman","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-3002-0","article-title":"Advances in the understanding of the mechanism of action of IVIg","volume":"255","author":"Hartung","year":"2008","journal-title":"J. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/iid3.167","article-title":"Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?","volume":"5","author":"Spindeldreher","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12026-014-8599-8","article-title":"Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells","volume":"60","author":"Mitrevski","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood-2014-05-576835","article-title":"Inhibition of Fc\u03b3R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc\u03b3RIIb in human macrophages","volume":"124","author":"Nagelkerke","year":"2014","journal-title":"Blood"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-120-6-199403150-00005","article-title":"High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"120","author":"Rostoker","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000188480","article-title":"Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Sch\u00f6nlein purpura. Preliminary results of a prospective uncontrolled trial","volume":"69","author":"Rostoker","year":"1995","journal-title":"Nephron"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","article-title":"Rituximab therapy for IgA-vasculitis with nephritis: A case series and review of the literature","volume":"65","author":"Fenoglio","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","article-title":"Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Sch\u00f6nlein)","volume":"70","author":"Maritati","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"102490","DOI":"10.1016\/j.autrev.2020.102490","article-title":"Rituximab treatment for IgA vasculitis: A systematic review","volume":"19","author":"Carbonell","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: A combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(95)92411-6","article-title":"Angiotensin receptor antagonists: Focus on losartan","volume":"346","author":"Johnston","year":"1995","journal-title":"Lancet"},{"key":"ref_115","first-page":"455","article-title":"Effects of ACE inhibition on the heart","volume":"9","author":"Gavras","year":"1995","journal-title":"J. Hum. Hypertens."},{"key":"ref_116","first-page":"227","article-title":"Disease progression, response to ACEI\/ATRA therapy and influence of ACE gene in IgA nephritis","volume":"4","author":"Woo","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"623052","DOI":"10.3389\/fimmu.2020.623052","article-title":"Omega 3 Fatty Acid and Skin Diseases","volume":"11","author":"Sawada","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1038\/s41598-018-30373-1","article-title":"Resolvin E1 attenuates murine psoriatic dermatitis","volume":"8","author":"Sawada","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41598-018-23623-9","article-title":"Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression","volume":"8","author":"Sawada","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.20150381","article-title":"Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses","volume":"212","author":"Sawada","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(84)92355-9","article-title":"Eicosapentaenoic acid and IgA nephropathy","volume":"1","author":"Hamazaki","year":"1984","journal-title":"Lancet"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1081\/JDI-200026763","article-title":"Treatment of severe IgA nephropathy with omega-3 fatty acids: The effect of a \u201cvery low dose\u201d regimen","volume":"26","author":"Alexopoulos","year":"2004","journal-title":"Ren. Fail."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group","volume":"331","author":"Donadio","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1133-1","article-title":"Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children","volume":"18","author":"Filler","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000046235","article-title":"Treatment of Henoch-Sch\u00f6nlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide","volume":"21","author":"Flynn","year":"2001","journal-title":"Am. J. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mpd.2000.103448","article-title":"Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: A clinical and histopathologic study","volume":"136","author":"Foster","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0272-6386(00)70192-2","article-title":"Complement activation through the lectin pathway in patients with Henoch-Sch\u00f6nlein purpura nephritis","volume":"35","author":"Endo","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000508841","article-title":"Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis","volume":"144","author":"Selvaskandan","year":"2020","journal-title":"Nephron"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jdv.14176","article-title":"Neutrophil-to-lymphocyte ratio: A biomarker for predicting systemic involvement in adult IgA vasculitis patients","volume":"31","author":"Nagy","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/1756-185X.13673","article-title":"Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"22","author":"Omma","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10067-018-4250-8","article-title":"MicroRNA expression in the affected skin of adult patients with IgA vasculitis","volume":"38","author":"Bolha","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/1756-185X.13904","article-title":"Analysis of the association between kidney injury biomarkers concentration and nephritis in immunoglobulin A vasculitis: A pediatric cohort study","volume":"23","author":"Dyga","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00296-019-04397-3","article-title":"Clinical significance of ANCA positivity in patients with IgA vasculitis: A retrospective monocentric study","volume":"39","author":"Kim","year":"2019","journal-title":"Rheumatol. Int."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Williams, C.E.C., Toner, A., Wright, R.D., and Oni, L. (2021). A systematic review of urine biomarkers in children with IgA vasculitis nephritis. Pediatr. Nephrol.","DOI":"10.1136\/archdischild-2021-rcpch.61"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/00325481.2019.1609814","article-title":"Do practical laboratory indices predict the outcomes of children with Henoch-Sch\u00f6nlein purpura?","volume":"131","author":"Ekinci","year":"2019","journal-title":"Postgrad. Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"He, X., Yin, W., Ding, Y., Cui, S.J., Luan, J., Zhao, P., Yue, X., Yu, C., Laing, X., and Zhao, Y. (2015). Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130536"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5603\/EP.a2020.0057","article-title":"Is adiponectin in children with immunoglobulin A vasculitis a suitable biomarker of nephritis in the course of the disease?","volume":"71","author":"Dyga","year":"2020","journal-title":"Endokrynol. Pol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10067-018-4248-2","article-title":"Antiphospholipid antibodies in adult IgA vasculitis: Observational study","volume":"38","author":"Rotar","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jid.2020.10.012","article-title":"Role of Epigenetics in the Regulation of Immune Functions of the Skin","volume":"141","author":"Sawada","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Sawada, Y., Nakatsuji, T., Dokoshi, T., Kulkarni, N.N., Liggins, M.C., Sen, G., and Gallo, R.L. (2021). Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8\/9. Sci. Immunol., 6.","DOI":"10.1126\/sciimmunol.abe1935"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40620-018-0482-6","article-title":"Defective activation of the MAPK\/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"31","author":"Milillo","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/annrheumdis-2017-212372","article-title":"Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis","volume":"77","author":"Carmona","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clim.2012.12.009","article-title":"Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch-Sch\u00f6nlein purpura","volume":"146","author":"Luo","year":"2013","journal-title":"Clin. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7538\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:30:27Z","timestamp":1760164227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":143,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147538"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147538","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}